企業プロフィール
Basilea Pharmaceutica 株価・ニュース・カタリスト
- ティッカー:
- BSLN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Switzerland and trades in the U
株価変動の要因
Current closing-price context is not available for BSLN.
企業概要
事業概要
Basilea Pharmaceutica is a specialty pharmaceutical company focused on infectious disease and oncology. Its business combines marketed products and development activity in niche therapeutic areas.
所在地とセクター分類
Basilea is headquartered in Switzerland and trades in the U.S. market. It sits in specialty pharma and anti-infectives.
ビジネスモデルの特徴
The company depends on product revenue, pipeline progress, and strategic commercialization in focused markets. Investors watch earnings, product launches, and development milestones.
バイオ業界での位置付け
Basilea occupies a specialty-pharma niche with catalyst sensitivity around infectious disease and oncology assets. It is more commercial than early-stage biotech but still tied to pipeline progress.
今後のカタリスト
- Basilea’s catalysts are antifungal and antibacterial product execution, plus any licensing or commercialization update that strengthens the portfolio. The company moves on steady recurring pharmaceutical demand.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。